Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
In responding to the article by Muller-Pebody and colleagues,1 Michael Hall and colleagues2 report that they use empiric cefotaxime monotherapy for suspected neonatal sepsis, contrary to the UK national guidelines, because they are concerned about aminoglycoside toxicity. They also state wrongly that the authors do not distinguish early- from late-onset sepsis.
The concerns about …
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.